NIH-funded postdoctoral (research associate) positions are immediately available for highly motivated individuals. We study the roles of the Nogo-B receptor (NgBR) and related epigenetic modification in regulating vascular cell functions, lipid metabolism, glucose homeostasis, and liver fibrosis in the context of metabolic diseases and diabetes-related vascular complications. NgBR is an embryonically lethal gene, and NgBR deficiency is involved in the pathogenesis of vascular malformations, hepatic steatosis, ferroptosis, and insulin resistance. Mechanistically, NgBR is essential for receptor tyrosine kinase signaling and histone protein posttranslational modifications. We are specifically interested in individuals with research experience in vascular biology, lipid biology, liver diseases, diabetes, and epigenetics. Publications in international peer-review journals and a doctoral degree in life sciences are required. The research will involve conditional knockout mice, cell culture, molecular biology, biochemical techniques, bulk RNA-seq, and single-cell RNA-seq. We also try to incorporate artificial intelligence and machine learning into our bioinformatics analysis. As one of the top medical schools, NYU Langone Health provides world-class research facilities to boost research innovation. NYU offers a highly collaborative scientific and warm, friendly environment and a competitive salary and benefit that follows the NIH standard. Our research website: https://medli.nyu.edu/faculty/qing-miao. Interested candidates should send a CV and a summary of their research experience and interests to Dr. Qing Robert Miao, Obesity and Diabetes Research Center, New York University Long Island School of Medicine, Mineola, NY 11501. Email: [email protected]
